Skip to content

Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey

Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey - Disease awareness and perspective of secondary immunodeficiency in Japanese physician -a web-based survey

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057802
Enrollment
500
Registered
2025-05-08
Start date
2025-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary immunodeficiency

Interventions

None listed

Sponsors

Takeda Pharmaceutical Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Physicians in hematology, general internal medicine and infectious diseases departments who practice hematological diseases

Exclusion criteria

Exclusion criteria: ?Physicians who have less than 3 years of practice excluding training period ?Physicians who work in a facility other than clinics, university hospitals, national and public hospitals, or public medical institutions/private hospitals ?Physicians who currently treating zero/none outpatients and inpatients ?Physicians who are related to Takeda and/or the Contract Research Organizations (CROs)

Design outcomes

Primary

MeasureTime frame
The level of disease awareness and perspective of SID practice.(At the time of web survey)

Secondary

MeasureTime frame
Treatment options, clinical evaluation, diagnosis, standard of care and management flow of SID. (At the time of web survey)

Countries

Japan

Contacts

Public ContactKiyoto Naito

Takeda Pharmaceutical Company Limited Japan Medial Office

kiyoto.naito@takeda.com03-3278-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026